Skip to main content
SpringerLink
Log in

STAT Signaling in Cancer: Insights into Pathogenesis and Treatment Strategies

  • Chapter
Signal Transduction in Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 115))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abe, A., Emi, N., Tanimoto, M., Terasaki, H., Marunouchi, T., & Saito, H. (1997). Fusion of the platelet-derived growth factor receptor b to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood, 90, 4271–4277.

    CAS  PubMed  Google Scholar 

  • Anderson, K. C., Jones, R. M., Morimoto, C., Leavitt, P., & Barut, B. A. (1989). Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73, 1915–1924.

    CAS  PubMed  Google Scholar 

  • Azam, M., Lee, C. K., Strehlow, I., & Schindler, C. (1997). Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity, 6, 691–701.

    Article  CAS  PubMed  Google Scholar 

  • Benekli, M., Xia, Z., Donohue, K. A., Ford, L. A., Pixley, L. A., Baer, M. R., Baumann, H., & Wetzler, M. (2002). Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood, 99, 252–257.

    Article  CAS  PubMed  Google Scholar 

  • Besser, D., Bromberg, J. F., Darnell, J. E., Jr., & Hanafusa, H. (1999). A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol. Cell. Biol., 19,1401–1409.

    CAS  PubMed  Google Scholar 

  • Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E., Jr. (1999). Stat3 as an oncogene. Cell, 98, 295–303.

    Article  CAS  PubMed  Google Scholar 

  • Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J. L., Nunez, G., Dalton, W. S., & Jove, R. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10, 105–115.

    CAS  PubMed  Google Scholar 

  • Chai, S. K., Nichols, G. L., & Rothman, P. (1997). Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol., 159, 4720–4728.

    CAS  PubMed  Google Scholar 

  • Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1997). Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279, 563–566.

    Google Scholar 

  • Chaturvedi, P., Reddy, M. V., & Reddy, E. P. (1998). Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene, 16, 1749–1758.

    Article  CAS  PubMed  Google Scholar 

  • Chen, T., Wang, L. H., & Farrar, W. L. (2000). Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res., 60, 2132–2135.

    CAS  PubMed  Google Scholar 

  • Endo, S., Zeng, Q., He, Y., Drenning, S. D., Watkins, S. L., Huang, L., & Rubin Grandis, J. (1999). Increased Stat3 activation in head and neck tumors in vivo. Proc. Amer. Assoc. Cancer Res., 40, 336.

    Google Scholar 

  • Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S., & Yoshimura, A. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921–924.

    CAS  PubMed  Google Scholar 

  • Eriksen, K. W., Kaltoft, K., Mikkelsen, G., Nielsen, M., Zhang, Q., Geisler, C., Nissen, M. H., Ropke, C., Wasik, M. A., & Odum, N. (2001). Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia, 15(5), 787–793

    Article  CAS  PubMed  Google Scholar 

  • Fernandes, A., Hamburger, A. W., & Gerwin, B. I. (1999). ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells. Int. J. Cancer, 83, 564–570.

    Article  CAS  PubMed  Google Scholar 

  • Frank, D. A., Robertson, M., Bonni, A., Ritz, J., & Greenberg, M. E. (1995). IL-2 signaling involves the phosphorylation of novel Stat proteins. Proc. Natl. Acad. Sci., 92, 7779–7783.

    CAS  PubMed  Google Scholar 

  • Frank, D. A., & Varticovski, L. (1996). BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia, 10, 1724–1730.

    CAS  PubMed  Google Scholar 

  • Frank, D. A., Mahajan, S., & Ritz, J. (1997). B lymphocytes from patients with chronic lymphocytic leukemia contain STAT1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest., 100, 3140–3148.

    CAS  PubMed  Google Scholar 

  • Gaemers, I. C., Vos, H. L., Volders, H. H., van der Valk, S. W., & Hilkens, J. (2001). A STAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J. Biol. Chem., 276, 6191–6199.

    Article  CAS  PubMed  Google Scholar 

  • Garcia, R., Yu, C.-L., Hudnall, A., Catlett, R., Nelson, K. L., Smithgall, T., Fujita, D. J., Ethier, S. P., & Jove, R. (1997). Constitutive activation of Stat3 in flbroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Diff., 8, 1267–1276.

    CAS  PubMed  Google Scholar 

  • Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J.-F., Capiod, J.-C., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., & Prin, L. (1996). STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood, 87, 1692–1697.

    CAS  PubMed  Google Scholar 

  • Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M.-Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998). Requirement of Stat3 but not Stat1 activation for epidermal growth factor-mediated cell growth in vitro. J. Clin. Inv., 102, 1385–1392.

    CAS  Google Scholar 

  • Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D., (2000). Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo, Proc Natl Acad Sci USA, 97(8), 4227–4232.

    Article  CAS  PubMed  Google Scholar 

  • Grandis, J. R., Zeng, Q., & Drenning, S. D. (2000). Epidermal growth factor receptor—mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope, 110(5 Pt 1), 868–874.

    CAS  Google Scholar 

  • Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H., & Naoe, T. (2000). Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene, 19, 624–631.

    Article  CAS  PubMed  Google Scholar 

  • Hilbert, D. M., Kopf, M., Mock, B. A., Kohler, G., & Rudikoff, S. (1995). Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med., 182, 243–248

    Article  CAS  PubMed  Google Scholar 

  • Hilbert, D. M., Migone, T.-S., Kopf, M., Leonard, W. J., & Rudikoff, S. (1996). Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity, 5, 81–89.

    Article  CAS  PubMed  Google Scholar 

  • Ilaria, R. L. J., Hawly, R. G., & Van Etten, R. A. (1999). Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood, 93, 4154–4166.

    CAS  PubMed  Google Scholar 

  • Jackson, P. K. (2001). A new RING for SUMO: wrestling transcription responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev., 15, 3053–3058.

    CAS  PubMed  Google Scholar 

  • Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002). Cancer statistics, 2002. CA Cancer J. Clin., 52, 23–47.

    PubMed  Google Scholar 

  • Joos, S., Kupper, M., Ohl, S., Von Bonin, F., Mechtersheimer, G., Bentz, M., Marynen, P., Moller, P., Pfreundschuh, M., Trumper, L., & Lichter, P. (2000). Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res., 60, 549–552.

    CAS  PubMed  Google Scholar 

  • Kawano, F., Yamaguchi, K., Nishimura, H., Tsuda, H., & Takatsuki, K. (1985). Variation in the clinical courses of adult T-cell leukemia. Cancer Res, 55, 851–856

    CAS  Google Scholar 

  • Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., & Kishimoto, T. (1988). Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83–85.

    Article  CAS  PubMed  Google Scholar 

  • Kirkwood, J. M., Farkas, D. L., Chakraborty, A., Dyer, K. F., Tweardy, D. J., Abernethy, J. L., Edington, H. D., Donnelly, S. S., & Becker, D. (1999). Systemic interferon-a (IFN-a) treatment leads to Stat3 inactivation in melanoma precursor lesions. Mol. Med., 5,11–20.

    CAS  PubMed  Google Scholar 

  • Klein, B., Zhang, X. G., Yang, L. Z., & Bataille, R. (1995). Interleukin-6 in human multiple myeloma. Blood, 85, 863–874.

    CAS  PubMed  Google Scholar 

  • Konopka, J. B., Watanabe, S. M., & Witte, O. N. (1984). An alteration of the human c-abl protein in K562 unmasks associated tyrosine kinase activity. Cell, 37, 1035–1042.

    Article  CAS  PubMed  Google Scholar 

  • Kube, D., Hotlick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., Heinrich, P., Diehl, V., & Tesch, H. (2001). STAT3 is constitutively activated in Hodgkin cell lines. Blood, 98, 762–770.

    Article  CAS  PubMed  Google Scholar 

  • Lacronique, V., Boreux, A., Monni, R., Dumon, S., Mauchauffe, M., Mayeux, P., Gouilleux, F., Berger, R., Gisselbrecht, S., Ghysdael, J., & Bernard, O. A. (2000). Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood, 95, 2076–2083.

    CAS  PubMed  Google Scholar 

  • Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchaufee, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., & Bernard, O. A. (1997). A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science, 278, 1309–1312.

    Article  CAS  PubMed  Google Scholar 

  • Levy, Y., Tsapis, A., & Brouet, J. C. (1991). Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J. Clin. Invest., 88, 696–699.

    CAS  PubMed  Google Scholar 

  • Lin, T. S., Mahajan, S., & Frank, D. A. (2000). STAT signaling in the pathogenesis and treatment of leukemias. Oncogene, 19, 2496–2504.

    CAS  PubMed  Google Scholar 

  • Liu, X., Robinson, G. W., Gouilleux, F., Groner, B., & Hennighausen, L. (1995). Cloning and expression of stat5 and an additional homologue (stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci., 92, 8831–8835.

    CAS  PubMed  Google Scholar 

  • Liu, X., Robinson, G. W., Wagner, K.-U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev., 11, 179–186.

    CAS  PubMed  Google Scholar 

  • Lund, T. C., Garcia, R., Medveczky, M. M., Jove, R., & Medveczky, P. G. (1997). Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck. J. Virol., 71, 6677–6682.

    CAS  PubMed  Google Scholar 

  • Lund, T. C., Prator, P. C., Medveczky, M. M., & Medveczky, P. G. (1999). The Lck binding domain of herpesvirus saimiri tip-484 constitutively activates Lck and STAT3 in T cells. J. Virol., 73, 1689–1694.

    CAS  PubMed  Google Scholar 

  • Mackarehtschain, K., Hardin, J. D., Moore, K. A., Boast, S., Goff, S. P., & Lemischka, I. R. (1995). Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity, 3, 147–161.

    Google Scholar 

  • Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., & Roifman, C. M. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645–648.

    Article  CAS  PubMed  Google Scholar 

  • Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O’Shea, J. J., Franchini, G., & Leonard, W. J. (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science, 269, 79–81.

    CAS  PubMed  Google Scholar 

  • Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Muller, C., Gruning, W., Kratz Albers, K., Serve, S., Steyr, C., Buchner, T., Kienast, J., Kanakura, Y., Berdel, W. E., & Serve, H. (2000), Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood, 96, 3907–3914.

    CAS  PubMed  Google Scholar 

  • Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994). Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science, 263, 1281–1284.

    CAS  PubMed  Google Scholar 

  • Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S., & Kishimoto, T. (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature, 387, 924–928.

    CAS  PubMed  Google Scholar 

  • Nieborowska-Skorska, M., Slupianek, A., Xue, L., Zhang, Q., Raghunath, P. N., Hoser, G., Wasik, M. A., Morris, S. W., & Skorski, T. (2001). Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. Cancer Res, 61(17), 6517–6523.

    Google Scholar 

  • Nielsen, M., Kaestel, C. G., Eriksen, K. W., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Ropke, C., & Odum, N. (1999). Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoidestumor cells. Leukemia, 13, 735–738.

    CAS  PubMed  Google Scholar 

  • Nielsen, M., Kaltoft, K., Nordahl, M., Ropke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Odum, N. (1997). Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc. Natl. Acad. Sci., 94, 6764–6769.

    CAS  PubMed  Google Scholar 

  • Nielsen, M., Nissen, M. H., Gerwien, J., Zocca, M.-B., Rasmussen, H. M., Nakajima, K., Ropke, C., Geisler, C., Kaltoft, K., & Odum, N. (2002). Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3. Blood, 99, 973–977.

    Article  CAS  PubMed  Google Scholar 

  • Niu, G., Heller, R., Catlett-Falcone, R., Coppola, D., Jaroszeski, M., Dalton, W., Jove, R., & Yu, H. (1999). Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res, 59(20), 5059–5063

    CAS  PubMed  Google Scholar 

  • Onishi, M., Nosaka, T., Misawa, K., Mui, A. L.-F., Gorman, D., McMahon, M., Miyajima, A., & Kitamura, T. (1998). Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol, 18, 3871–3879.

    CAS  PubMed  Google Scholar 

  • O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002). Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell, 109, S121–S131.

    CAS  PubMed  Google Scholar 

  • Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H., & Marynen, P. (1997). Fusion of Tel, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase Jak2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood, 90, 2535–2540.

    CAS  PubMed  Google Scholar 

  • Rawat, R., Rainey, G. J., Thompson, C. D., Frazier-Jessen, M. R., Brown, R. T., & Nordan, R. P. (2000). Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas. Blood, 96, 3514–3521.

    CAS  PubMed  Google Scholar 

  • Ross, T., Bernard, O., Berger, R., & Gilliland, D. G. (1998). Fusion of the Huntington interacting protein 1 to platelet-derived growth factor b receptor (PDGFbR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood, 91, 4419–4426.

    CAS  PubMed  Google Scholar 

  • Sartor, C. I., Dziubinski, M. L., Yu, C. L., Jove, R., & Ethier, S. P. (1997). Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res., 57, 978–987.

    CAS  PubMed  Google Scholar 

  • Schwaller, J., Frantsve, J., Aster, J., Williams, I. R., Tomasson, M. H., Ross, T. S., Peeters, P., Van Rompaey, L., Van Etten, R. A., Ilaria, R. J., Marynen, P., & Gilliland, D. G. (1998). Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo-and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J., 17, 5321–5333.

    Article  CAS  PubMed  Google Scholar 

  • Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J. C., Williams, I. R., Lee, C.-K., Gerthner, R., Kitamura, T., Frantsve, J., Anastasiadou, E., Loh, M. L., Levy, D. E., Ihle, J. N., & Gilliland, D. G, (2000). Stat5 is essential for the myelo-and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell, 6, 693–704.

    Article  CAS  PubMed  Google Scholar 

  • Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A., Doherty, P. C., Grosveld, G., Paul, W. E., & Ihle, J. N. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature, 380, 630–633

    Article  CAS  PubMed  Google Scholar 

  • Shimozaki, K., Nakajima, K., Hirano, T., & Nagata, S. (1997). Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem., 272, 25184–25189.

    Article  CAS  PubMed  Google Scholar 

  • Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Patterson, B., Trumper, L., Kapp, U., & Mak, T. M. (2002). Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood, 99, 618–626.

    CAS  PubMed  Google Scholar 

  • Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177–182.

    CAS  PubMed  Google Scholar 

  • Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., & Hilton, D. J. (1997). A family of cytokine-inducible inhibitors of signaling. Nature, 387, 917–921.

    CAS  PubMed  Google Scholar 

  • Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996). Essential role of Stat6 in IL-4 signalling. Nature, 380, 627–630.

    Article  CAS  PubMed  Google Scholar 

  • Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T.-S., Patel, B. K. R., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., Leonard, W. J., Waldmann, T., & Franchini, G. (1997). Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci., 94, 13897–13902.

    Article  CAS  PubMed  Google Scholar 

  • Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001). Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem, 276(48), 45443–45455.

    Article  CAS  PubMed  Google Scholar 

  • Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S.-H., Ram, P. A., Waxman, D. J., & Davey, H. W. (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci., 94, 7239–7244.

    Article  CAS  PubMed  Google Scholar 

  • Wakao, H., Gouilleux, F., & Groner, B. (1994). Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J., 13, 2182–2191.

    CAS  PubMed  Google Scholar 

  • Wang, L. H., Yang, X. Y., Kirken, R. A., Resau, J. H., & Farrar, W. L. (2000), Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven TH2 cell response. Blood, 95, 1249–1257.

    CAS  PubMed  Google Scholar 

  • Watson, C. J., & Miller, W. R. (1995). Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer, 71, 840–844.

    CAS  PubMed  Google Scholar 

  • Weber-Nordt, R. M., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V., Mertelsmann, R., & Finke, J. (1996). Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood, 88, 809–816.

    CAS  PubMed  Google Scholar 

  • Wemmer, D. E. (2000). Designed sequence-specific minor groove ligands. Annu. Rev. Biophys. Biomol. Struct., 29, 439–461.

    Article  CAS  PubMed  Google Scholar 

  • White, S., Szewczyk, J. W., Turner, J. M., Baird, E. E., & Dervan, P. B. (1998). Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature, 391, 468–471.

    Article  CAS  PubMed  Google Scholar 

  • Xia, Z., Baer, M. R., Block, A. W., Baumann, H., & Wetzler, M. (1998). Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res., 58, 3173–3180.

    CAS  PubMed  Google Scholar 

  • Xia, Z., Sait, S. N. J., Baer, M. R., Barcos, M., Donohue, K. A., Lawrence, D., Ford, L. A., Block, A. M. W., Baumann, H., & Wetzler, M. (2001). Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk. Res., 25, 473–482.

    Article  CAS  PubMed  Google Scholar 

  • Xia, Z., Salzler, R. R., Kunz, D. P., Baer, M. R., Kazim, L., Baumann, H., & Wetzler, M. (2001). A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts. Cancer Res., 61, 1747–1753.

    CAS  PubMed  Google Scholar 

  • Xu, X., Kang, S. H., Heidenreich, O., Okerholm, M., O’Shea, J. J., & Nerenberg, M. I. (1995). Constitutive activation of different Jak kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J. Clin. Inv., 96, 1548–1555.

    CAS  Google Scholar 

  • Yan, R., Qureshi, S., Zhong, Z., Wen, Z., & Darnell, J. E., Jr. (1995). Nucleic Acids Res., 23, 459–463.

    CAS  PubMed  Google Scholar 

  • Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y., & Naoe, T. (1997). Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on large series of patients and cell lines. Leukemia, 11, 1605–1609.

    Article  CAS  PubMed  Google Scholar 

  • Yu, C. L., Jove, R., & Burakoff, S. J. (1997). Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J. Immunol., 159, 5206–5210.

    CAS  PubMed  Google Scholar 

  • Zhang, S., Fukuda, S., Lee, Y., Hangoc, G., Cooper, S., Spolski, R., Leonard, W. J., & Broxmeyer, H. E. (2000). Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J. Exp. Med., 192, 719–728.

    Article  CAS  PubMed  Google Scholar 

  • Zong, C., Yan, R., August, A., Darnell, J. E., Jr., & Hanafusa, H. (1996). Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J., 15, 4515–4525.

    CAS  PubMed  Google Scholar 

  • Zong, C. S., Chan, J., Levy, D. E., Horvath, C., Sadowski, H. B., & Wang, L. H. (2000). Mechanism of STAT3 activation by insulin-like growth factor I receptor. J. Biol. Chem., 275, 15099–15105.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Adult Oncology Dana-Farber Cancer Institute, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA

    David A. Frank

  2. Departments of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA

    David A. Frank

Authors
  1. David A. Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

    David A. Frank MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Frank, D.A. (2004). STAT Signaling in Cancer: Insights into Pathogenesis and Treatment Strategies. In: Frank, D.A. (eds) Signal Transduction in Cancer. Cancer Treatment and Research, vol 115. Springer, Boston, MA. https://doi.org/10.1007/0-306-48158-8_11

Download citation

  • DOI: https://doi.org/10.1007/0-306-48158-8_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7340-3

  • Online ISBN: 978-0-306-48158-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation